Yu Wen - Concepedia

Author

Yu Wen

Central China Normal University ORCID

Also Known As

Yu (Yvonne) Wen, Yu Mei Wen, Yu Wen

Publications

404

Citations

H-Index

Concepts

All Affiliations

Central China Normal University Chinese Academy of Sciences Shanghai Institute of Materia Medica Wuhan Institute of Virology Shaoxing University

About

Yu Wen is an author at Central China Normal University specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	57
2	Immunology	3	3	57
3	Vaccine Development	3	3	57
4	Humoral Immunity	2	2	35
5	T Cell Immunity	2	2	35

Yu Wen

Publications

334

Citations

H-Index

Page 1

	Year	Citations
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy Xi Chen, Zhijie Xu, Tongfei Li, Biomarker Research	2024	59
Self-Adjuvanting Lipoprotein Conjugate αGalCer-RBD Induces Potent Immunity against SARS-CoV-2 and its Variants of Concern Jian Wang, Yu Wen, Shihao Zhou, Journal of Medicinal Chemistry	2022	39
MPLA-Adjuvanted Liposomes Encapsulating S-Trimer or RBD or S1, but Not S-ECD, Elicit Robust Neutralization Against SARS-CoV-2 and Variants of Concern Jian Wang, Xuguang Yin, Yu Wen, Journal of Medicinal Chemistry	2022	31
Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine Shihao Zhou, Yuting Li, Ruyan Zhang, Frontiers in Immunology	2022	28
RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concern Shihao Zhou, Ruyan Zhang, Haiwei Zhang, Chemical Communications	2022	24
pH-Sensitive and Biodegradable Mn<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>·3H<sub>2</sub>O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity Shihao Zhou, Ruyan Zhang, Zi-Wei You, ACS Applied Materials & Interfaces	2023	24
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19 Yu Wen, Ruyan Zhang, Jian Wang, Journal of Controlled Release VaccinationPotent VaccineVaccine DevelopmentImmunologyAdjuvant-protein Conjugate	2023	22
Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2 Dong Ding, Yu Wen, Chun-Miao Liao, Journal of Medicinal Chemistry	2023	20
A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern Ruyan Zhang, Xuguang Yin, Shihao Zhou, Chemical Communications VaccinationTernary Adjuvant SystemVaccine DevelopmentVaccine ResearchProtein Vaccine	2022	18
Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern Ruyan Zhang, Shihao Zhou, Chen-Bin He, ACS Infectious Diseases VaccinationBuilt-in Tlr7aVaccine DevelopmentVaccine TargetImmunology	2022	17

Page 1